Metabolic dependencies of acute myeloid leukemia stem cells

被引：1

作者：

Shi, Xiangguo ^{[1
,2
]}

Feng, Mengdie ^{[1
]}

Nakada, Daisuke ^{[1
]}

机构：

[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA

[2] Penn State Univ, Coll Med, Dept Pediat, Div Pediat Hematol Oncol, Hershey, PA 16801 USA

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2024年 / 120卷 / 04期

关键词：

Acute myeloid leukemia; Leukemia stem cell; Metabolic regulation; AMINO-ACID-METABOLISM; OXIDATIVE-PHOSPHORYLATION; SELF-RENEWAL; GLUCOSE-METABOLISM; INHIBITION; CHEMOTHERAPY; RESISTANCE; VENETOCLAX; THERAPY; NAMPT;

D O I：

10.1007/s12185-024-03789-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy primarily driven by an immature population of AML cells termed leukemia stem cells (LSCs) that are implicated in AML development, chemoresistance, and relapse. An emerging area of research in AML focuses on identifying and targeting the aberrant metabolism in LSCs. Dysregulated metabolism is involved in sustaining functional properties of LSCs, impeding myeloid differentiation, and evading programmed cell death, both in the process of leukemogenesis and in response to chemotherapy. This review discusses recent discoveries regarding the aberrant metabolic processes of AML LSCs that have begun to change the therapeutic landscape of AML.

引用

页码：427 / 438

页数：12

共 50 条

[31] Leukemia Stem Cells in the Pathogenesis, Progression, and Treatment of Acute Myeloid Leukemia
Joshi, Kanak
Zhang, Lei
Breslin, Peter
Zhang, Jiwang
LEUKEMIA STEM CELLS IN HEMATOLOGIC MALIGNANCIES, 2019, 1143 : 95 - 128
[32] Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
Castro, Isabel
Sampaio-Marques, Belem
Ludovico, Paula
CELLS, 2019, 8 (09)
[33] Cellular and Molecular State of Myeloid Leukemia Stem Cells
Xie, Xueqin
Feng, Mengdie
Wang, Qifan
Wang, Jiazhen
Yin, Rong
Li, Yicun
Zhang, Haojian
LEUKEMIA STEM CELLS IN HEMATOLOGIC MALIGNANCIES, 2019, 1143 : 41 - 57
[34] Targeting Metabolic Dependencies Fueling the TCA Cycle to Circumvent Therapy Resistance in Acute Myeloid Leukemia
Boet, Emeline
Sarry, Jean-Emmanuel
CANCER RESEARCH, 2024, 84 (07) : 950 - 952
[35] Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
Renner, Kathrin
Seilbeck, Anton
Kauer, Nathalie
Ugele, Ines
Siska, Peter J.
Brummer, Christina
Bruss, Christina
Decking, Sonja-Maria
Fante, Matthias
Schmidt, Astrid
Hammon, Kathrin
Singer, Katrin
Klobuch, Sebastian
Thomas, Simone
Gottfried, Eva
Peter, Katrin
Kreutz, Marina
FRONTIERS IN PHARMACOLOGY, 2018, 9
[36] Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax
Culp-Hill, Rachel
Stevens, Brett M.
Jones, Courtney L.
Pei, Shanshan
Dzieciatkowska, Monika
Minhajuddin, Mohammad
Jordan, Craig T.
D'Alessandro, Angelo
METABOLITES, 2023, 13 (04)
[37] Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities
Stahl, Maximilian
Kim, Tae Kon
Zeidan, Amer M.
WORLD JOURNAL OF STEM CELLS, 2016, 8 (10): : 316 - 331
[38] Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells
Zhao, Haijun
Jiang, Yuelong
Lin, Fusheng
Zhong, Mengya
Tan, Jinshui
Zhou, Yong
Liu, Long
Li, Guowei
Deng, Manman
Xu, Bing
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
[39] Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia
van Gils, Noortje
Denkers, Fedor
Smit, Linda
FRONTIERS IN ONCOLOGY, 2021, 11
[40] Inhibition of mitochondria induces apoptosis and reduces telomere length and activity in acute myeloid leukemia stem cells
Valipour, Behnaz
Davari, Sahar
Farahzadi, Raheleh
Pourrasol, Shahram
Mehran, Niloofar
Asl, Khadijeh Dizaji
Altaha, Seyed Mansour
Hojjati, Zahra
Charoudeh, Hojjatollah Nozad
CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (08) : 1477 - 1487

← 1 2 3 4 5 →